NCT04997005 is a clinical trial of AMIStem-P in Arthrosis, sponsored by Medacta International SA.

Who is sponsoring NCT04997005?

NCT04997005 is sponsored by Medacta International SA.

What drugs are being tested in NCT04997005?

Interventions in NCT04997005: AMIStem-P.

What condition does NCT04997005 study?

NCT04997005 studies Arthrosis, Traumatic Arthritis, Rheumatoid Polyarthritis, Congenital Hip Dysplasia, Avascular Necrosis of the Femoral Head.

Is NCT04997005 still recruiting?

NCT04997005 is currently active, enrolled. Last updated 8 May 2025.

Last reviewed 2025-05-08 · How we verify

NCT04997005

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Medacta International AMIStem-P Post-Marketing Surveillance Study

Active, enrolled Last updated 8 May 2025

What this trial tests

trial testing AMIStem-P in Arthrosis in 550 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

26 April 2019

Primary endpoint
30 April 2029

31 December 2032

Quick facts

Lead sponsor	Medacta International SA
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	550
Start date	26 April 2019
Primary completion	30 April 2029
Estimated completion	31 December 2032
Sites	5 locations across France

Drugs / interventions tested

AMIStem-P

Conditions studied

Arthrosis — all drugs for Arthrosis →
Traumatic Arthritis — all drugs for Traumatic Arthritis →
Rheumatoid Polyarthritis — all drugs for Rheumatoid Polyarthritis →
Congenital Hip Dysplasia — all drugs for Congenital Hip Dysplasia →

Sponsor

Medacta International SA — full company profile →

Who can join

Adults 18 to 85, any sex, with Arthrosis or Traumatic Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a Post-Market Surveillance study of AMIStem-P femoral stem prosthesis

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Arthrosis

Currently open trials in the same condition.

NCT06917235 — Wrist and Carpal Arthrodeses. A 1-year Follow-up Study. · recruiting
NCT05887284 — Investigation of the Clinical Efficacy of Low-dose Ionizing Radiation in the Treatment of Osteoarthritis · NA · recruiting

Other Medacta International SA trials

Trials by the same sponsor.

NCT06775704 — Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System · recruiting
NCT06640764 — Multicentre SMS Study - FR · recruiting
NCT06578897 — A Post-Market, Retrospective Study on 3D Metal Tibial and Femoral Cones · completed
NCT05679232 — Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty · NA · recruiting
NCT05785364 — A Post Market Surveillance Study About the MONOCER Cup · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04997005 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medacta International SA
Last refreshed: 8 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04997005.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing